Emerging variants of concern in Saudi Arabian SARS-CoV-2 isolates

References

1. 1.↵
   1. Yurkovetskiy L,
   2. Wang X,
   3. Pascal KE,
   4. Tomkins-Tinch C,
   5. Nyalile TP,
   6. Wang Y, et al.

   Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell 2020; 183: 739–751.

   OpenUrlCrossRef
2. 2.↵
   1. Munnink BB,
   2. Sikkema RS,
   3. Nieuwenhuijse DF,
   4. Molenaar RJ,
   5. Munger E,
   6. Molenkamp R, et al.

   Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science 2021; 371: 172–177.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Lopez Bernal J,
   2. Andrews N,
   3. Gower C,
   4. Gallagher E,
   5. Simmons R,
   6. Thelwall S, et al.

   Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant. N Engl J Med 2021; 385: 585–594.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Shu Y,
   2. McCauley J.

   GISAID: Global initiative on sharing all influenza data–from vision to reality. Eurosurveillance 2017; 22: 30494.

   OpenUrlCrossRef
5. 5.↵
   1. Leung K,
   2. Shum MH,
   3. Leung GM,
   4. Lam TT,
   5. Wu JT.

   Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Eurosurveillance 2021; 26: 2002106.

   OpenUrl